From Where Does Biosynthetic Recombinant Human Type Insulin Is Derived?

Modern technology makes it possible to produce the biosynthetic recombinant human type insulin derived from the bacteria or from the yeast, and semi synthetic human type insulin converted form the pork.

Soon it will probably to possible to dispense with pig and beef entirely. Japan and the United States deserve credit for much of the research and the advances in this field. Genetic engineering has made it possible to train microorganisms to produce insulin. In recent years the insulin identical to human insulin has been prepare form microorganism known as E. coil, utilizing a method known as recombinant DNA techniques. Here, the bacteria have been genetically altered by the addition of the human gene for the insulin production. Two products are now commercially available for the  injections in the United States and marketed as Humulin and Novalin. They are widely used in the treatment of diabetic patients at present.

It would in fact, be more sensible in situation of illness to activate desired enzymes rather than to inhibitor undesired enzymes. Pharmacology and the medicine have achieved a great deal in this direction, but it has unfortunately found little application as yet.